FDA approves saxagliptin/metformin for Type II diabetes

FDA approved an NDA from Bristol-Myers Squibb Co. (NYSE:BMY) and AstraZeneca plc (LSE:AZN; NYSE:AZN) for Kombiglyze XR to treat Type II diabetes. The companies plan to launch the fixed-dose combinatio...